India allows Serum Institute to enrol 7-11 year olds in Novavax COVID-19 vaccine trial

BENGALURU (Reuters) -India's drug regulator on Tuesday allowed vaccine maker Serum Institute to enrol kids aged 7-11 years for its trial of U.S. drugmaker Novavax's COVID-19 vaccine, as the country…

Zydus Cadila seeks emergency use authorisation for ZyCoV-D COVID-19 vaccine for 12 years, above

New Delhi [India], July 1 (ANI): Pharmaceutical major Zydus Cadila on Thursday applied for Emergency Use Authorisation (EUA) seeking approval from the Drugs Controller General of India (DCGI) for the…